467 related articles for article (PubMed ID: 24292195)
1. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.
India Project Team of the International Cancer Genome Consortium
Nat Commun; 2013; 4():2873. PubMed ID: 24292195
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
[TBL] [Abstract][Full Text] [Related]
3. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
[TBL] [Abstract][Full Text] [Related]
4. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
5. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
[TBL] [Abstract][Full Text] [Related]
7. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
[TBL] [Abstract][Full Text] [Related]
8. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
10. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
[TBL] [Abstract][Full Text] [Related]
13. Pathway based prognostic gene expression profile of buccal and gingivo-buccal oral squamous cell carcinoma in smokeless tobacco chewers.
Prasad K; Rao R; Augustine D; Sowmya SV; Haragannavar V; Sagar P; Sreedhar P
Head Neck; 2019 Feb; 41(2):388-397. PubMed ID: 30536474
[TBL] [Abstract][Full Text] [Related]
14. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
15. Genome sequencing reveals molecular subgroups in oral epithelial dysplasia.
Márquez A; Mujica I; Jordan N; Baez P; Tarquinio S; Nunes J; Adorno D; Martínez B; Morales-Pison S; Fernandez-Ramires R
Braz Oral Res; 2023; 37():e063. PubMed ID: 37341234
[TBL] [Abstract][Full Text] [Related]
16. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
17. Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers.
Arunkumar G; Murugan AK; Nagarajan M; Ajay C; Rajaraman R; Munirajan AK
Oral Dis; 2017 Jul; 23(5):669-673. PubMed ID: 28181739
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
[TBL] [Abstract][Full Text] [Related]
19. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.
Pickering CR; Zhang J; Yoo SY; Bengtsson L; Moorthy S; Neskey DM; Zhao M; Ortega Alves MV; Chang K; Drummond J; Cortez E; Xie TX; Zhang D; Chung W; Issa JP; Zweidler-McKay PA; Wu X; El-Naggar AK; Weinstein JN; Wang J; Muzny DM; Gibbs RA; Wheeler DA; Myers JN; Frederick MJ
Cancer Discov; 2013 Jul; 3(7):770-81. PubMed ID: 23619168
[TBL] [Abstract][Full Text] [Related]
20. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
